Allosteric modulators of the nmda receptor

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/04 (2006.01) C07K 14/435 (2006.01)

Patent

CA 2202513

Novel compounds and compositions for modulating NMDA receptor function comprising Conantokin-G and derivatives thereof; methods for modulating NMDA receptor function and methods for treating neuropsychopharmacological disorders, using the novel compounds and compositions of the invention; and a method for screening compounds capable of binding to a novel allosteric modulatory site, are described.

L'invention se rapporte à de nouveaux composés et compositions destinés à moduler la fonction du récepteur de NMDA et comprenant la Conantokine-G et des dérivés de celle-ci; à des procédés de modulation de la fonction du récepteur de NMDA et à des procédés de traitement des troubles neuropsychopharmacologiques et d'utilisation de ces nouvelles compositions, ainsi qu'à un procédé de criblage de composés capables de se fixer à un nouveau site modulateur allostérique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Allosteric modulators of the nmda receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Allosteric modulators of the nmda receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allosteric modulators of the nmda receptor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1663187

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.